Target intelligence / Profile preview

C-type lectin receptor (on dendritic cell) (CLR (on DC) or DC-CLR)

Target
CLR (on DC) or DC-CLR
Molecular classification
Receptor, Pattern recognition receptor (PRR), Lectin, C-type lectin-like receptor (CLR or CTLR), Some also classified as "immunoreceptor" or "cell surface glycoprotein"
01

Overview

C-type lectin receptors (CLRs) on dendritic cells are a diverse family of calcium-dependent carbohydrate-binding proteins that function predominantly as pattern recognition receptors, recognizing pathogen- and damage-associated glycans and self-antigens. They mediate key innate and adaptive immune activities by capturing and presenting antigens, modulating cytokine profiles, polarizing T cell responses, and participating in immunological tolerance or activation. Individual CLRs on dendritic cells—such as DC-SIGN, Dectin-1, Dectin-2, CLEC9A, and DCIR—play distinct and sometimes overlapping roles in immunity, pathogen recognition, vaccination, and disease processes, with their expression and function finely regulated by maturation and environmental stimuli

Other names
CLR (C-type lectin receptor)DC-CLRC-type lectin family receptorDendritic cell lectin receptorIncludes: DC-SIGN (CD209)Dectin-1 (CLEC7A)Dectin-2 (CLEC6A)DCIR (CLEC4A)CLEC9AMINCLE (CLEC4E)
02

Mechanism of action

Antigen targeting: Use of glycosylated antigens or antibody–antigen conjugates to direct delivery and presentation by dendritic cells via these receptors. Immune modulation: Modulation of downstream signaling, cytokine production, and T cell polarization through receptor engagement (e.g., via ITAM/hemITAM or ITIM signaling pathways, crosstalk with TLRs or other PRRs)

03

Biological functions

Immune responseAntigen recognition and uptakeAntigen presentationModulation of T cell polarizationSignal transductionRegulation of cytokine productionPathogen recognitionCrosstalk with other PRRs (e.g., Toll-like receptor)Induction of tolerance or immunity depending on ligand/context
04

Disease associations

Infection (bacterial, viral, fungal, parasitic)InflammationCancer (tumor immune modulation and recognition of tumor glycans)Allergic/atopic diseaseAutoimmune diseaseOther immune system–related disorders
05

Safety considerations

Potential for inappropriate immune activation or tolerance (e.g., unwanted immunosuppression or exacerbated inflammation/allergy depending on ligand and context)Risk of impaired pathogen clearance or tolerance induction in targeting strategiesPossibility of autoimmunity if tolerance mechanisms are dysregulated
06

Interacting drugs

No approved drugs directly targeting DC-CLRs, but multiple vaccine/adjuvant strategies actively target or utilize these receptors for antigen delivery and immunomodulation.

1 more in the full profile.

07

Biomarkers

Expression of CLR subtypes (e.g., DC-SIGN, Dectin-1, Dectin-2, CLEC9A) can be used as dendritic cell subset markers.Tumor-associated glycans (e.g., Lewis antigens, GalNAc) detected by certain CLRs in cancer immunoprofiling.CLR expression profiling in inflammation, infection, or allergy for stratifying immune responses

Beyond the preview

Go deeper on C-type lectin receptor (on dendritic cell) (CLR (on DC) or DC-CLR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on C-type lectin receptor (on dendritic cell) (CLR (on DC) or DC-CLR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call